SiNtx Technologies Inc (SINT)

[SmokerX]

in October 2013, we entered into a new European sales agent agreement with K2M, Inc.

Pursuant to the terms of the non-exclusive private label agreement, Amedica will supply BoTEC Medical with proprietary silicon nitride spinal interbody fusion devices for distribution and sale in their worldwide markets. WinnTi Medical was founded by a group of former senior executives from leading orthopedic companies in China, such as Kanghui, Johnson & Johnson, Medtronic, Stryker and Zimmer. -December 2015

Under the distribution agreement, Weigao Orthopedic will have exclusive rights for the sale, marketing and distribution of Amedica-branded silicon nitride spinal implants in the People’s Republic of China, With more than 50,000 minimum unit sales to occur within the first two years following CFDA clearance,-2016

announced a collaboration with Kyocera Industrial Ceramics Corporation, a worldwide leading ceramics producer, to manufacture medical devices from Amedica's Silicon Nitride biomaterial at Kyocera's Vancouver, WA facility.2013

Kyocera agreement allows for explosive ramp up in sales that Amedica's manufacturing facility cannot develop their production fast enough to meet product demand.

The China deal depends on 2 things. China's willingness for CFDA approval and AMDA's willingness to fund it. Is China unwilling to approve? meaning their intentions where to put the kabosh on WinnTi strategic partnership? and lock it up? Is Amedica unwilling/unable to fund CFDA approval? Do they wish to allow the deal to expire with no action? If so why sign it in the first place? How will the recent $15mill deal digest into this? I believe it is medtronic that is strategically partnered with Weigao as well.